August 11, 2021

AUGUST 2021 NEWSLETTER

Welcome to the August edition of the AMR - One Health Consortium newsletter <<First Name>>! We hope that you are enjoying the warm weather and taking some much needed vacation time to relax. As always, if you have something you would like to see in this newsletter, please email amronehealth@ucalgary.ca, and add us to your address book to prevent this newsletter from going to spam.

Consortium News

JEI Survey

Reminder: JEI Survey

PIs and Co-I’s receiving funding from the MIF, please submit your annual JEI reporting survey by August 26th. Your survey data will contribute to our mandatory report of the 2020-21 year. Contact Samantha at samantha.larose@ucalgary.ca if you have any questions about this reporting period. 
 
AMR: A One Health Approach Virtual Seminar Series

AMR: A One Health Approach Virtual Seminar Series

There is still time to register for the AMR: A One Health Approach Virtual Seminar Series! Join distinguished instructors from various institutions with different backgrounds and expertise related to AMR and One Health for 24 virtual live sessions via Zoom, September 14 - December 17, 2021. Open to students, adult learners and professionals from all over the world. No prerequisites to participate. Access to this virtual seminar series is by donation. Click here for more information and to register now! 
 
Antimicrobials for Lunch

Antimicrobials for Lunch

Mark your calendars! The Antimicrobials for Lunch Series will be happening again this fall, online via Zoom. There will be 10 Friday sessions, Oct 1 - Dec 3, 2021, 12-1PM (MT). Each session consists of 3 Consortium project presentation updates and a Q&A period.

Join Zoom meeting: https://ucalgary.zoom.us/j/5702265429
Password: 453525

Funding Opportunities

Mitacs Accelerate Program

Mitacs has extended the eligibility of their flagship Accelerate program. Now college students and undergraduates can apply and it’s open to hospitals and municipalities
• College students and undergrads can now put their talent to work with a paid internship at an organization that needs their expertise
• Those organizations now include hospitals and municipalities in addition to businesses and not-for-profit organizations
• Internships start at four months and projects can count multiple internships 
 

Accelerate Industrial Postdoc

The Mitacs Accelerate Industrial Postdoc is now valued at $60K per year, for up to three years, for a postdoctoral fellow. This increase in funding means more budget is available than with standard Mitacs Accelerate internships to:
• Build a longer-term collaboration with a company or not-for-profit organization
• Enable postdocs to apply their expertise to real-world problems
• Connect with a potential employer

Interested applicants can apply at any time. For more information visit the website or contact accelerate@mitacs.ca
 

CIHR Project Grant

CIHR Project Grant

The Canadian Institutes of Health Research (CIHR) Project Grant program is designed to capture ideas with the greatest potential to advance health-related knowledge, health research, health care, health systems, and/or health outcomes.  It supports projects with a specific purpose and a defined endpoint.  The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches. Within the investment allocated to each Project Grant competition, there will be a funding envelope of $16.25M dedicated to large grants, and $14.95M dedicated to supporting applications with an Indigenous health research focus. Registration is now open and required to be submitted to CIHR. More details available here

Registration deadline: Aug 18, 2021
UofC RSO internal application deadline: Sep 13, 2021

 
NSERC I2I Grants

NSERC Idea to Innovation (I2I) Grants

The objective of the Idea to Innovation (I2I) Grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector and promote its transfer to a new or established Canadian company. The I2I Grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. This is achieved through four defined phases by providing crucial assistance in the early stages of technology validation and market connection: Market Assessment, Phase I, Phase IIa, Phase IIb. Click here to learn more. 

Sponsor application deadlines: Sep 27, 2021

Our Researchers in the News

The Delta Surge Shows We Need Vaccine Passports. But North America Is Resisting

The Delta Surge Shows We Need Vaccine Passports. But North America Is Resisting

Lorian Hardcastle

After a heartening slowdown in COVID-19 cases in North America, a “fourth wave”—largely driven by the Delta variant is threatening to undo much of the continent’s progress. Vaccine passports are an effective way to encourage some people to get vaccinated because they offer pre-pandemic freedoms while minimizing the risk of catching the virus for both vaccinated and unvaccinated folks. UofC assistant law professor Lorian Hardcastle acknowledged that there is often a tension between individual rights and the “greater good” when it comes to public health, “many people would argue that in the case of an infectious disease with physical and economic consequences, you can't have total autonomy.” Click here to read the full article.
 

Alberta travellers with a mix of COVID-19 vaccines not allowed in some countries

Daniel Gregson

When Albertans started receiving their COVID-19 vaccinations about seven months ago doctors didn't anticipate the possibility that fully-vaccinated people might ever have problems travelling and yet, that is happening. Dr. Daniel Gregson, associate professor in the Cumming School of Medicine at the UofC says health officials didn't know what was going to happen with vaccines and that health officials in Canada didn't do anything wrong by mixing doses. "We knew that we were going to have different vaccines that were going to be effective," said Gregson. "We didn't anticipate that some jurisdictions, especially this AstraZeneca not being approved in United States, I mean that's moderately immoral because they're producing vaccines for the rest of the world." Click here to watch the full video. 
 

Court topples Canadian ruling that one of world's most expensive drugs is excessively priced

Court topples Canadian ruling that one of world's most expensive drugs is excessively priced

Aidan Hollis

Soliris was originally approved to treat two blood disorders affecting about 180 Canadians — paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) — with the list price in Canada for a year of treatment ranging from $500,000 to $700,000. Canada’s drug-cost regulator took rare action in response, ruling that Soliris was excessively priced. It ordered manufacturer Alexion Pharmaceuticals to pay back surplus revenue over eight years, but the firm challenged that edict and has just won a key legal victory in defence of Soliris’s steep price tag. Aidan Hollis, UofC economics professor and drug-pricing expert, said he was taken aback by the strongly worded ruling, saying the board had seemed to have solid arguments. Read the full article here
 

Alberta primary-care physicians get vaccine hesitancy roadmap

Alberta primary-care physicians get vaccine hesitancy roadmap

Myles Leslie

Family physicians and other primary-care doctors were “thrust into” the role of being vaccine counsellors throughout the COVID-19 pandemic, UofC researchers say. However, not all primary-care experts are trained or equipped to talk to patients about specific concerns with COVID-19 vaccines. It’s that responsibility that spurred Myles Leslie, School of Public Policy assistant professor, and his team to develop the Vaccine Hesitancy Guide to help doctors navigate difficult conversations with patients who have reservations about being immunized against the novel coronavirus. Read the full article here
 

Opinion: A day to shine a light on Fragile X Syndrome

Opinion: A day to shine a light on Fragile X Syndrome

Raymond Turner

More than 250 prominent buildings, bridges and monuments worldwide were illuminated on July 22 to help spread the word about Fragile X syndrome, the most common inherited known cause of autism and intellectual disabilities. Researchers continue to investigate ways to restore the missing protein in individuals diagnosed with Fragile X. Dr. Raymond W. Turner and his team at the Hotchkiss Brain Institute, Alberta Children’s Hospital Research Institute, and Owerko Centre at the University of Calgary’s Cumming School of Medicine have made a significant advancement in the treatment of Fragile X, but more research is required and depends to a large extent on increased global awareness, especially as more clinical trials are launched, and more scientists and pharma companies become engaged. Read more here

Join Drs. Tim Mcallister, Kim Stanford and Kim Ominski for new episodes of Cows on the Planet once every fortnight. This podcast provides a balanced perspective on issues important to the beef industry with a focus on sharing science-based information to increase public confidence in Canadian beef production practices and consumption of Canadian beef.

Visit https://cows-on-the-planet.simplecast.com/ to listen now!
Also available on Amazon Music and Apple Podcasts.
Facebook
Twitter
Instagram

Events

5th AMR Conference

5th AMR Conference

Summer Edition | AMR Briefing Sessions

Aug 24 - 26, 2021

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. Each day will offer an AMR briefing session in the afternoon on a dedicated topic, including live speakers, high-level panel discussions, and interactive exchange with the audience.

Day 1: Status quo & COVID-19 Impact: What has changed after one year of COVID?
Day 2: Financing & Investing: What’s new with funds, incubators and accelerators?
Day 3: Policy & Incentives: What can we learn from best practices to go ahead?

Click here for more details. 
 

BSL4ZNet

2021 BSL4ZNet International Conference: Preparing and responding to new post-pandemic challenges

Sep 23 - Oct 14, 2021

The Biosafety Level 4 Zoonotic Laboratory Networks (BSL4ZNet) is organizing a series of virtual sessions that feature keynote speakers, expert panelists and a moderated dialogue with questions and answers. The conference will be focused on the following thematic areas:

  1. Emerging and re-emerging pathogens
  2. BSL3 and BSL4 biosafety and biosecurity
  3. One Health
  4. Zoonotic outbreaks & pandemics: Science Policy and Science Diplomacy

Please click here for more information. 
 

One Health in the 21st Century Conference

One Health in the 21st Century Conference 2021

Oslo, Norway

Nov 3, 2021

The Centre for Global Health (CGH) at the University of Oslo (UiO), together with the Norwegian Veterinary Institute (NVI), the Norwegian Institute of Public Health (NIPH) and the Norwegian University of Life Sciences (NMBU), is assembling the One Health Norwegian milieu and organizing the One Health in the 21st Century 2021 Conference on International One Health Day (November 3). We invite you to save the date and pre-register for the event. More information regarding the program, invited speakers and location will be made available soon. This conference will, if permissible, be in-person at UiO, otherwise digital. Click here for more information. 
 

World Anti-Microbial Resistance Congress 2021

Washington, DC

Nov 8 - 9, 2021

The World Anti-Microbial Resistance Congress focusses on one of the most important parts of the AMR challenge: tackling the supply problem. The world's largest AMR conference will bring together all the stakeholders involved in developing new antibiotic drugs. For more information and to download the prospectus please click here.
 

World Vaccine & Immunotherapy Congress West Coast 2021

San Diego, CA

Nov 30 - Dec 2, 2021

The World Vaccine & Immunotherapy Congress is part of an award-winning series of conferences and exhibitions that are continuously growing becoming the largest and most established vaccine meetings of its kind across the globe. With 500+ potential customers in attendance there will be opportunities to meet & network with contacts who are looking for solutions to commercial and scientific challenges in manufacturing, clinical trials, strategy and regulation for immune monitoring, AMR and vaccine development for infectious diseases and cancer immunotherapies. Early bird tickets available until Aug 27! Click here for more information.

Recruitment Opportunities

Postdoctoral Position in Public Health Microbiology
The lab of Drs. Gregory Tyrrell and Tanis Dingle, PhD, D(ABMM) at the University of Alberta is looking for a highly motivated and skilled Postdoctoral Fellow to take a leading role on studying antibiotic resistance as it relates to epidemiological trends. This will involve analyzing antimicrobial susceptibility data and resistance mechanisms for organisms such as Mycobacteria, Gram negative and Gram-positive organisms from patients in Alberta. This position will remain open until filled. For more details and to apply please click here

Postdoctoral Research Scientist
The Cumming School of Medicine at the University of Calgary in Conjunction with the AMR - One Health Consortium has an immediate opening for a postdoctoral research scientist with experience in the analysis of complex databases to analyze the effects of antimicrobial resistance on the economic and clinical consequences of anti-microbial resistance in patients with bacteremia. The position is a one year contract. Interested candidates should submit a letter of interest and CV to Dr. Daniel Gregson at dgregson@ucalgary.ca. Click here for more information. 

Please check out our website for more trainee opportunities.

Resources

The following documents provide updates on the conduct of research and clinical trails for researchers and research teams. Please visit the following pages to keep up-to-date with institutional specific directives. 
Copyright © 2021 AMR - One Health Consortium, All rights reserved.
Thank you for joining our newsletter.

Our mailing address is:
University of Calgary
3280 Hospital Drive NW
Calgary, AB T2N 4Z6
amronehealth@ucalgary.ca

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
AMR - One Health Consortium · 3280 Hospital Drive NW · Calgary, Ab t2n 1n4 · Canada

Email Marketing Powered by Mailchimp